Putting the puzzle together: SGLT2 inhibitors from prevention to treatment of heart failure

Eur Heart J. 2022 Nov 1;43(41):4433-4435. doi: 10.1093/eurheartj/ehac483.

Josephine Harrington^{1

2}, Stefan Anker^{3

4}, Javed Butler^{5

6}

¹ Duke University Department of Medicine, Division of Cardiology, Durham, NC, USA.
² Duke Clinical Research Institute, Duke University Medical Center, Durham, NC, USA.
³ Department of Cardiology (CVK); and Berlin Institute of Health Center for Regenerative Therapies (BCRT); German Centre for Cardiovascular Research (DZHK) partner site Berlin, Charité Universitätsmedizin Berlin, Berlin, Germany.
⁴ Institute of Heart Disease, Wroclaw Medical University, Wroclaw, Poland.
⁵ Baylor Scott and White Research Institute, 3434 Live Oak St, Dallas, TX, 75204, USA.
⁶ Department of Medicine, University of Mississippi, Jackson, MS, USA.

No abstract available

Publication types